Related Experiment Videos
Phenothiazine treatment and respiratory distress syndrome in a child
Insights
High-dose methotrimeprazine meleate, a phenothiazine antipsychotic, led to respiratory distress syndrome in an 11-year-old boy. This case highlights the potential for phenothiazine overdose to cause severe respiratory complications.
Area of Science:
- Pediatric intensive care
- Pharmacology
- Toxicology
Background:
- Phenothiazine antipsychotics, like methotrimeprazine meleate, are used to manage various conditions.
- Understanding the dose-dependent effects and prolonged action of these drugs is crucial.
Observation:
- An 11-year-old boy developed respiratory distress syndrome after receiving a high dose of methotrimeprazine meleate.
- The patient required 13 days of intensive care and support.
Findings:
- The adverse event suggests a potential link between phenothiazine overdose and respiratory distress syndrome.
- Persistent organ effects observed are consistent with the known prolonged biological action of phenothiazine metabolites.
Implications:
- This case underscores the importance of careful dosing and monitoring of methotrimeprazine meleate in pediatric patients.
- The association warrants further consideration in clinical practice and toxicology studies.
Abstract:
An 11-year-old boy who was treated with a relatively high dose of methotrimeprazine meleate (Levemepromazine) a phenothiazine antipsychotic drug, was admitted to the pediatric intensive care unit suffering from respiratory distress syndrome. He required intensive treatment and support for 13 days. The persistent effects of methotrimeprazine meleate on various organs are typical of the prolonged biological action of the phenothiazine metabolites. The association of phenothiazine overdose and respiratory distress syndrome merits consideration.